In COVID-19, the main target of SARS-CoV-2 is ACE2 receptor, a critical enzyme of the renin–angiotensin–aldosterone system (RAAS), which promotes oxidative stress via stimulating NADPH Oxidase, an action principally mediated by Ang II [24]. The gene discussed is FMO5; the disease is COVID-19.